Advanced aesthetic treatments initiate complex biological processes that extend far beyond the treatment room. Regeneration, recovery, and cellular adaptation unfold over days and weeks, not minutes. Yet in practice, the support provided after these treatments often remains limited to traditional aftercare, primarily focused on surface-level care and comfort.

While topical products play an important role in maintaining barrier function and hydration, they are inherently limited in how deeply they can support the biological processes activated during professional procedures. As treatments become more advanced, this gap between what is initiated in-clinic and what can realistically be supported afterward becomes increasingly visible.

At the same time, the biological response itself does not stop once a patient leaves the clinic. The body continues to adapt, recover, and remodel, requiring consistency, continuity, and support that fits into real life.

Dermalune was created to address this disconnect. The company exists to bridge the gap between scientific understanding, clinical intervention, and practical post-treatment support. By introducing controlled, technology-based aftercare that extends beyond isolated clinical sessions, Dermalune enables biological processes initiated in-clinic to be supported in a way that is both realistic and structurally consistent.

This is not about replacing professional treatments, but about ensuring that what is started in the clinic is not left unsupported once the patient returns to daily life.

Dermalune is building a new framework for post-treatment support, one in which aftercare is no longer viewed as an optional add-on, but as a structured continuation of professional care.

Our long-term vision is a model where technology-driven aftercare is aligned with clinical practice, operating within clearly defined parameters rather than informal recommendations or uncontrolled consumer use. In this model, continuity becomes the standard, not the exception, and biological support extends naturally beyond the treatment room without increasing operational burden for professionals.

We aim to contribute to a future in which post-treatment support is approached with the same level of responsibility, control, and intent as in-clinic procedures themselves. A future where professionals retain authority over the quality of care associated with their treatments, and where patients benefit from consistent, biologically aligned support throughout the full recovery and regeneration process.

Dermalune’s role is to provide the infrastructure that makes this possible, quietly, responsibly, and in alignment with professional standards.

Dermalune is available exclusively through selected professional partners. The system is not offered through open consumer channels and cannot be purchased independently without professional involvement. Access is intentionally structured around clinical guidance and treatment planning, ensuring that the technology remains aligned with professional standards and appropriate use.

Professionals introduce Dermalune as part of a broader treatment strategy and provide the necessary context, recommendation, and follow-up. When a patient proceeds, the system is supplied through the clinic’s partnership with Dermalune. Fulfilment, logistics, and operational handling are managed centrally, while access remains clinically mediated rather than consumer-driven.

This structure allows clinics to offer advanced, technology-based aftercare without inventory management, upfront investment, or financial exposure. Partners receive the same margin they would earn through traditional in-clinic sales, without the operational complexity or risk associated with purchasing, stocking, and distributing physical devices.

The partnership model is designed to remain flexible. Should a partner prefer a more traditional distribution approach in the future, this can be accommodated in alignment with the clinic’s operational preferences. Dermalune’s role remains focused on supporting professional care, regardless of the chosen fulfilment structure.

By retaining control over availability while separating clinical responsibility from operational execution, Dermalune preserves professional authority and continuity of care. Technology remains positioned as an integrated part of the treatment plan, not as a standalone consumer product or referral-based sales mechanism.